FDA TO RECONSIDER PART 11 AFTER HEARING FROM INDUSTRY

Devices & Diagnostics Letter
KEYWORDS Industry
A A

Breaking its silence on the Part 11 issue for the first time since issuing an August 2003 revised guidance, the FDA announced last week that it intends to reach out to industry to find ways to make the rule "less prescriptive."

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00